AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount ...

If New York legislators have questions about the efficacy of the 340B Drug Pricing Program, they should look closely at a recent 340B transparency report from the Minnesota Department of Health — a ...

April 8 (Reuters) - AbbVie has filed a lawsuit against the U.S. government, seeking clearer guidance on patients eligible for ...

AbbVie sues HHS over 340B patient definition to tighten eligibility and prevent duplicate discounts in federal drug pricing ...

New York City has long stood at the center of New York’s fight to expand healthcare access. Our boroughs, especially in ...

Catholic healthcare was not started nor inspired from profit and loss statements or a desire to drive more shareholder value. Instead, through acts of mercy, women religious crossed oceans on ...

Pharmaceutical companies are spending hundreds of millions lobbying elected officials to try and persuade them to gut the ...

Tuesday’s bill gives powers to the Attorney General’s Office to further enforce state law that prohibits manufacturers from ...

Drug companies want to end it. This is not a partisan issue. It is a math issue. And for the patients and communities we serve, it is a survival issue.

"The savings from this program support pharmacy services, emergency care, behavioral health, and care for patients who are ...

The secretary of Indiana’s Family and Social Services Administration wants to change how hospitals purchase discounted drugs ...

Both drugmakers filed complaints in the U.S. District Court for the Western District of Washington and asked judges for an ...